American Journal of Health Behavior · 2018 · 28 citations · 64 references
Public HealthHealth BehaviorHealth PromotionAdolescent HealthHealth CommunicationTobacco ControlTobacco Control PolicyTobacco PolicyTobacco PreventionTobacco RegulationTobacco UseTobacco Use PreventionAdult Smoking PerceptionsAnti-tobacco AdvertisingElectronic CigarettesSemi-structured InterviewsYoung Adult Tobacco UseYoung Adulthood
Objectives With increased alternative tobacco product (ATP) use and lagging public health action, we explored perceptions of ATPs, anti-tobacco messaging, and tobacco regulation among young adults. Methods Semi-structured interviews were conducted with 60 Georgia college students aged 18-25 using: (1) cigarettes, little cigars/cigarillos (LCCs), smokeless tobacco, or e-cigarettes ≥15 days of the past 30; or (2) hookah ≥10 of the past 30 days (due to lower frequency of use). Of 99 participants recruited, 80 consented, and 60 participated. Results Participants were on average 21.01 years old (SD = 2.07), 56.7% women, and 65.0% black; 56.7% reported current use of cigarettes, 43.3% LCCs, 26.7% smokeless tobacco, 45.0% e-cigarettes, and 41.7% hookah. Cigarettes were perceived as most harmful to health and most addictive. E-cigarettes and hookah were generally regarded as lowest risk. Many indicated that ATP risk information was limited or inaccessible and that most anti-tobacco campaigns were irrelevant to ATPs. Participants requested more research and dissemination of evidence regarding ATP risks and need for ATP regulation. Conclusions In light of low risk perceptions regarding ATPs among young adults, research, anti-tobacco campaigns, and regulation must address their known and potential risks.
64
Allison Tong, Peter Sainsbury, Jonathan C. Craig · International Journal for Quality in Health Care · 2007 · 41.6K citations · Full text
Historical Origins of the Health Belief Model
Irwin M. Rosenstock · Health Education Monographs · 1974 · 5.9K citations · Full text
Electronic cigarettes for smoking cessation: a randomised controlled trial
Chris Bullen, Colin Howe, Murray Laugesen et al. · The Lancet · 2013 · 1.1K citations